plerixafor has been researched along with t140 peptide in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Broach, JR; Fujii, N; Haribabu, B; Hiramatu, K; Manfredi, JP; Navenot, JM; Omagari, A; Pei, G; Peiper, SC; Tamamura, H; Zhang, WB | 1 |
| Arakaki, R; Fujii, N; Hattori, T; Ibuka, T; Kanbara, K; Nakashima, H; Omagari, A; Otaka, A; Tamamura, H; Xu, Y; Yamamoto, N; Zhang, X | 1 |
| Fujii, N; Gotoh, K; Kanamoto, T; Kanbara, K; Mochizuki, K; Nakashima, H; Tamamura, H; Yoshimori, M | 1 |
| Benton, BK; Dohlman, HG; Hamilton, A; Lolis, E; Manfredi, JP; Sachpatzidis, A; Wang, H | 1 |
| Bendall, LJ; Bradstock, KF; Gottlieb, DJ; Juarez, J | 1 |
| Fujii, N; Murray, JL; Peiper, SC; Shao, W; Tamamura, H; Trent, JO; Wang, ZX | 1 |
| Bertolotti-Ciarlet, A; Doms, RW; Haggarty, B; Hoxie, JA; Huang, CC; Jordan, AP; Kwong, PD; Leslie, GJ; Lin, G; Nolan, KM; Romano, J | 1 |
| Fujii, N; Jones, O; Liapi, A; Nadarajah, B; Parnavelas, JG; Pritchett, J | 1 |
| Berchanski, A; Borkow, G; Kollet, O; Lapidot, A; Lapidot, T; Pal, B; Peled, A | 1 |
| Barr, FG; Drukala, J; Grymula, K; Kucia, M; Ratajczak, J; Ratajczak, MZ; Tarnowski, M; Wysoczynski, M | 1 |
| Li, Y; Meng, X; Wang, G; Xiang, Y; Yang, X | 1 |
11 other study(ies) available for plerixafor and t140 peptide
| Article | Year |
|---|---|
A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists.
Topics: Amino Acid Substitution; Animals; Anti-HIV Agents; Benzylamines; CHO Cells; Cricetinae; Cyclams; Genes, Reporter; Genetic Variation; GTP-Binding Proteins; Heterocyclic Compounds; Humans; Oligopeptides; Open Reading Frames; Point Mutation; Protein Conformation; Receptors, CXCR4; Recombinant Proteins; Saccharomyces cerevisiae; Signal Transduction; Transfection | 2002 |
A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140.
Topics: Amino Acid Sequence; Anti-HIV Agents; Antimicrobial Cationic Peptides; Benzylamines; Cells, Cultured; Chemokine CXCL12; Chemokines, CXC; Circular Dichroism; Cyclams; DNA-Binding Proteins; Heterocyclic Compounds; HIV-1; Molecular Sequence Data; Oligopeptides; Peptides; Peptides, Cyclic; Receptors, CXCR4; T-Lymphocytes | 1998 |
Increase of R5 HIV-1 infection and CCR5 expression in T cells treated with high concentrations of CXCR4 antagonists and SDF-1.
Topics: Animals; Anti-HIV Agents; Antibodies, Monoclonal; Benzylamines; CD4 Antigens; CD4-Positive T-Lymphocytes; Chemokine CXCL12; Chemokines; Chemokines, CXC; Chlorocebus aethiops; COS Cells; Cyclams; Drug Synergism; Gene Expression Regulation; Heterocyclic Compounds; HIV Long Terminal Repeat; HIV-1; Humans; Methionine; Oligopeptides; Peptide Fragments; Receptors, CCR5; Receptors, CXCR4; Transfection; Tumor Cells, Cultured; Virus Replication; Zidovudine | 2001 |
Identification of allosteric peptide agonists of CXCR4.
Topics: Animals; Anti-HIV Agents; Benzylamines; Binding Sites; Chemotaxis; Cyclams; Flow Cytometry; Gene Library; Heterocyclic Compounds; Humans; Mice; Mutation; Oligopeptides; Rats; Receptors, CXCR4; Saccharomyces cerevisiae | 2003 |
Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro.
Topics: Antineoplastic Agents; Benzylamines; Cell Division; Chemokine CXCL12; Chemokines, CXC; Chemotaxis; Coculture Techniques; Cyclams; Dexamethasone; Drug Synergism; Heterocyclic Compounds; Humans; Oligopeptides; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, CXCR4; Stromal Cells; Vincristine | 2003 |
Lipid bilayer simulations of CXCR4 with inverse agonists and weak partial agonists.
Topics: Amino Acid Substitution; Benzylamines; Computer Simulation; Cyclams; Heterocyclic Compounds; Lipid Bilayers; Membrane Proteins; Models, Molecular; Oligopeptides; Protein Binding; Protein Structure, Tertiary; Receptors, CXCR4; Receptors, G-Protein-Coupled | 2003 |
Replication-competent variants of human immunodeficiency virus type 2 lacking the V3 loop exhibit resistance to chemokine receptor antagonists.
Topics: Anti-HIV Agents; Benzylamines; CCR5 Receptor Antagonists; CD4 Antigens; Cell Line; Cyclams; Drug Resistance, Viral; Heterocyclic Compounds; HIV Envelope Protein gp120; HIV Envelope Protein gp41; HIV-1; HIV-2; Humans; Oligopeptides; Protein Structure, Secondary; Receptors, CCR5; Receptors, CXCR4; Sequence Deletion; Virus Internalization; Virus Replication | 2007 |
Stromal-derived factor 1 signalling regulates radial and tangential migration in the developing cerebral cortex.
Topics: Animals; Anti-HIV Agents; Benzylamines; Cell Differentiation; Cell Line; Cell Movement; Cerebral Cortex; Chemokine CXCL12; Cyclams; Gene Expression Regulation, Developmental; Heterocyclic Compounds; Humans; Interneurons; Neurons; Oligopeptides; Organ Culture Techniques; Rats; Receptors, CXCR4; Signal Transduction; Stem Cells | 2008 |
NeoR6 inhibits HIV-1-CXCR4 interaction without affecting CXCL12 chemotaxis activity.
Topics: Aminoglycosides; Anti-HIV Agents; Antibodies, Monoclonal; Arginine; Benzylamines; Cell Line, Tumor; Chemokine CXCL12; Chemotaxis; Cyclams; Gene Expression Regulation; Heterocyclic Compounds; HIV-1; Humans; Neomycin; Oligopeptides; Protein Binding; Receptors, CXCR4 | 2008 |
Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas.
Topics: Animals; Benzylamines; Cell Adhesion; Cell Growth Processes; Cell Line, Tumor; Cell Movement; Chemokine CXCL11; Chemokine CXCL12; Cyclams; Down-Regulation; Endothelial Cells; Fibronectins; Heterocyclic Compounds; Humans; Matrix Metalloproteinases; Mice; Mice, SCID; Oligopeptides; Pertussis Toxin; Phosphorylation; Receptors, CXCR; Receptors, CXCR4; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Tissue Inhibitor of Metalloproteinases | 2010 |
The study of targeted blocking SDF-1/CXCR4 signaling pathway with three antagonists on MMPs, type II collagen, and aggrecan levels in articular cartilage of guinea pigs.
Topics: Aggrecans; Animals; Benzylamines; Cartilage; Cartilage, Articular; Chemokine CXCL12; Cyclams; Guinea Pigs; Male; Matrix Metalloproteinases; Oligopeptides; Peptides; Receptors, CXCR4; Signal Transduction | 2020 |